Great question Brabo - one I had not even thought of asking, as I have been focused on future events rather than past ones. I have no idea what the correct answer may be and we'll probably never know. Money, technical development, research, vision, horsepower? They all come to mind. But my reality is as I've stated. PEMF is now approved and specifically for post-op eye surgery patients, prescribed by surgeons to hasten healing.
I didn't know it was 10 years ago, but does that elapsed time not give even greater credibility to PEMF and BIEl, inasmuch as the FDA did not do an about face in say 2006 on its previous BIEL approval? Was the previous approval for a company other than BIEL? Did BIEL buy that idea and approval and product and form a new compnany? 10 years is a long time and I don't know how long the current org and management have been in the driver's seat.
But whatever, the company is where it is now, with its new applications before an august body - the FDA - charged with the responsibility of protecting us and the treatment for the indications they have been asked to approve. On a product already approved by the same FDA that approved the eye surgery treatment 10 years ago. As I said in last post, next?
Next for me was to look up BioElectronics and to my suprise found it was a small public company trading at a ridiculously low price, so I bought some shares. My current next is what happens when BIEL's latest applications are approved? Wish I could afford to buy a ton more.
